Glen Eagle Advisors, LLC Thermo Fisher Scientific Inc. Transaction History

Glen Eagle Advisors, LLC

$593 Billion
Q3 2024

A detailed history of Glen Eagle Advisors, LLC transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 878 shares of TMO stock, worth $462,864. This represents 0.09% of its overall portfolio holdings.

Number of Shares

878

Previous 885 0.79%

Holding current value

$462,864

Previous $489 Million 10.97%

% of portfolio

0.09%

Previous 0.09%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$531.86 - $624.21 $3,723 - $4,369	-7 Reduced 0.79%	878 $543 Million
Q2 2024 Aug 14, 2024	SELL	$541.52 - $599.02 $220,398 - $243,801	-407 Reduced 31.5%	885 $489 Million
Q1 2024 Jul 03, 2024	BUY	$528.82 - $599.43 $485,456 - $550,276	918 New	918 $534 Million
Q4 2023 Aug 13, 2024	SELL	$431.41 - $532.94 $49,612 - $61,288	-115 Reduced 10.47%	983 $522 Million
Q3 2023 Aug 13, 2024	SELL	$498.29 - $574.41 $32,887 - $37,911	-66 Reduced 5.67%	1,098 $556 Million
Q2 2023 Aug 13, 2024	SELL	$508.46 - $591.13 $1,525 - $1,773	-3 Reduced 0.26%	1,164 $607 Million
Q1 2023 Aug 13, 2024	BUY	$535.0 - $604.82 $2,675 - $3,024	5 Added 0.43%	1,167 $673 Million
Q4 2022 Aug 13, 2024	BUY	$484.71 - $571.37 $16,480 - $19,426	34 Added 3.01%	1,162 $640 Million
Q3 2022 Aug 13, 2024	SELL	$507.19 - $604.49 $2,535 - $3,022	-5 Reduced 0.44%	1,128 $572 Million
Q2 2022 Aug 13, 2024	SELL	$500.9 - $612.21 $2,504 - $3,061	-5 Reduced 0.44%	1,133 $616 Million
Q1 2022 Aug 13, 2024	SELL	$524.0 - $644.92 $23,580 - $29,021	-45 Reduced 3.8%	1,138 $672 Million
Q3 2021 Aug 13, 2024	SELL	$509.53 - $609.78 $7,642 - $9,146	-15 Reduced 1.25%	1,183 $676 Million
Q2 2021 Aug 13, 2024	SELL	$441.0 - $508.24 $14,994 - $17,280	-34 Reduced 2.76%	1,198 $604 Million
Q1 2021 Aug 13, 2024	SELL	$439.85 - $518.83 $10,996 - $12,970	-25 Reduced 1.99%	1,232 $562 Million
Q4 2020 Aug 13, 2024	BUY	$435.06 - $527.66 $147,485 - $178,876	339 Added 36.93%	1,257 $585 Million
Q3 2020 Aug 13, 2024	SELL	$359.77 - $441.52 $10,433 - $12,804	-29 Reduced 2.23%	1,273 $562 Million
Q2 2020 Aug 13, 2024	BUY	$275.2 - $362.34 $2,752 - $3,623	10 Added 0.77%	1,302 $472 Million
Q1 2019 Aug 13, 2024	BUY	$212.17 - $273.72 $79,351 - $102,371	374 Added 40.74%	1,292 $354 Million
Q3 2018 Aug 13, 2024	BUY	$205.57 - $244.32 $4,111 - $4,886	20 Added 1.55%	1,312 $320 Million
Q2 2018 Aug 13, 2024	SELL	$203.14 - $219.53 $53.8 Million - $58.2 Million	-265,043 Reduced 99.51%	1,292 $268 Million
Q1 2018 Aug 14, 2024	BUY	$192.98 - $224.11 $72,174 - $83,817	374 Added 40.74%	1,292 $267 Million
Q1 2018 Aug 13, 2024	BUY	$192.98 - $224.11 $51.1 Million - $59.4 Million	265,043 Added 20514.16%	266,335 $267 Million
Q3 2017 Aug 13, 2024	BUY	$171.74 - $194.04 $64,230 - $72,570	374 Added 40.74%	1,292 $244 Million
Q4 2016 Aug 12, 2024	BUY	N/A	1,664	2,582 $364 Million

Others Institutions Holding TMO

# of Institutions

2,835

Shares Held

333M

Call Options Held

2.37M

Put Options Held

2.75M

View Full List

About THERMO FISHER SCIENTIFIC INC.

Ticker TMO
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 391,788,992
Market Cap $207B
Description
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...

More about TMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glen Eagle Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Glen Eagle Advisors, LLC with notifications on news.

Account

Glen Eagle Advisors, LLC Thermo Fisher Scientific Inc. Transaction History